The former heavyweight champion says psychedelics would have helped him with his mental health during his career. Some scientists and companies agree
Articles
Getting People to Help Changes Everything: William Cook, CEO of MindLeap
Mydecine Innovations Group is a psychedelics company that The Dales Report has been watching closely this past year.
Texas And Louisiana Governors Signal They’ll Sign Marijuana Reform Bills On Their Desks
The governors of Texas and Louisiana on Thursday separately indicated that they will sign marijuana reform bills that have recently been delivered to their desks.
MindMed’s New CEO Well-Prepared For Next Stage of Corporate Development
Co-Founder JR Rahn has stepped down as CEO of MindMed. His replacement, Robert Barrow, brings a wealth of clinical trials experience.
Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US
HaluGen Life Sciences' test evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy
Magic Mushrooms Helped Me Cope With Postpartum Depression
In 2014, during my first pregnancy, I felt happy and healthy almost all the time.
Heritage Cannabis launches weed-infused freezies for summer
Just in time for summer, Heritage Cannabis Holdings Corp. has announced the launch of RADsicles, a cannabis-infused frozen edible meant to help consumers beat the heat with an intoxicating twist.
MindMed Announces Chief Executive Officer Transition
JR Rahn is stepping down as MindMed's CEO, to be replaced by Chief Development Officer, Robert Barrow.
Massachusetts Approves Cannabis Delivery with Focus on Equity
Massachusetts Cannabis Control Commission launches new delivery licenses, awarding access to those who need it most.
Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise
Central banks aren't "accepting" higher levels of price inflation. They are being run over by it.
Are Psychedelics The Ultimate Brain-Repair Drugs?
Psychedelic drugs increasingly appear to be powerful medicinal tools to rebuild broken brains.
Connecticut Senate Approves Marijuana Legalization Bill, Days Before Session Ends
The Connecticut Senate early Tuesday morning passed a bill to legalize marijuana, sending the proposal to the House for final approval with just days left in the legislative session.
Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market
After just uplisting to the TSX in Canada, Field Trip Health has applied to uplist to the NASDAQ in the U.S.
Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms
Mydecine announces identifying 40 previously unknown "novel compounds" among dozens of mushroom species it has screened.
Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Burnout and Distress with Psychedelic-Assisted Psychotherapy
Cybin is launching a new clinical trial to address "COVID-related burnout and distress", supported by its new EMBARK psychotherapy model.